share_log

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36

HC Wainwright & Co.維持對Aadi Bioscience的買入,將目標股價下調至36美元
Benzinga ·  2023/11/13 18:15

HC Wainwright & Co. analyst Robert Burns maintains Aadi Bioscience (NASDAQ:AADI) with a Buy and lowers the price target from $45 to $36.

HC Wainwright & Co. 分析師羅伯特·伯恩斯維持Aadi Bioscience(納斯達克股票代碼:AADI)的買入,並將目標股價從45美元下調至36美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論